Tag: multiple sclerosis (relapsing remitting)

MS Hospital Visits Increase in Warmer Weather

Individuals with multiple sclerosis (MS) seek additional acute medical care during periods of unusually warm weather, a new study has found, raising concerns about possible...

Anti-CD20s Linked to Higher COVID-19 Severity in MS

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Like other people, patients with multiple sclerosis (MS) who become infected...

Natalizumab Postinfusion Reactions Rare; Is Monitoring Necessary?

Reactions to the infusion of natalizumab (Tysabri) for the treatment of multiple sclerosis (MS) are very uncommon, are usually mild, and nearly always occur during,...

Vitamin D Deficiency Linked to Early Cognitive Impairment in MS

Vitamin D deficiency detected at the time of diagnosis of multiple sclerosis (MS) is associated with cognitive impairment and may also affect disability, according to...

NfL Levels Linked to Worse Disability in Real-World MS

Elevations in serum neurofilament light chain levels (sNfL) in people with multiple sclerosis (MS) are significantly linked to worse neurologic function, clinical disability, and lower...

Vascular Comorbidity in MS Linked to Atrophy, Functional Decline

Vascular comorbidities, including diabetes and hypertension, are linked to significantly lower measures of neurologic function in people with multiple sclerosis (MS) vs patients without these...

COVID-19 Risks No Higher in Patients With Multiple Sclerosis

The risk of severe outcomes from COVID-19 infection in patients with multiple sclerosis seems to align with that seen in the general population, new US...

Lower Rituximab Dose as Effective, Safer in MS

Further data suggesting that a lower dose of rituximab seems to offer similar effectiveness with a better safety profile than higher doses commonly used have...

Masitinib Impresses in ‘Nonactive’ Progressive MS

The investigational drug, masitinib (AB Science), which has a completely new mechanism of action for multiple sclerosis (MS), has shown a positive result in slowing...

Cardiovascular Risk Factors Linked to Brain Atrophy in MS

Dr Raffaello Bonacchi The presence of cardiovascular risk factors in patients with multiple sclerosis (MS) is associated with a greater degree of brain atrophy even...

Ofatumumab Shows High Elimination of Disease Activity in MS

With ofatumumab (Arzerra, Novartis), a fully human anti-CD20 monoclonal antibody, there is a greater likelihood of there being no evidence of disease activity (NEDA-3) for...

Depression Linked to Neuro Dysfunction, Brain Lesions in MS

Depression is associated with decreased neurologic function and new brain lesions in patients with multiple sclerosis (MS), new research suggests. In an observational study of...

Initial High-Efficacy MS Therapy Tied to Less Disability Later

Starting treatment for relapsing-remitting multiple sclerosis (MS) with high-efficacy therapy (HET) is associated with lower long-term disability compared with a step-wise increase to reach more...

Joint ACTRIMS/ECTRIMS Conference Still a Go Despite Pandemic

What your doctor is reading on Medscape.com: APRIL 22, 2020 — The show will go on. In some shape or form, organizers of...